News & Blog

Tag Archives: FDA

GBM AGILE: A Community Galvanized

“GBM is just unacceptable…we no longer accept the status quo.” – Dr. Anna Barker Last week, you likely took notice of the press release, guest blog from Dr. Anna Barker, and a flurry of social media activity related to the announcement of the GBM AGILE coalition and clinical trial. As NBTS is co-chairing the GBM […]

Cancer Research Takes the National Spotlight This Week

Two announcements this week thrust the importance of funding biomedical research into the national spotlight, yet again. This Wednesday, Vice President Joe Biden stepped in front of a podium in the White House Rose Garden and made a long anticipated announcement: his decision regarding a presidential bid. However, after the Vice President revealed his plan […]

Brain Tumor Groups Come Together for New Imaging Effort

When an athlete injures their knee, ankle, shoulder, etc. they will often need to go for an “MRI” to determine the extent of the damage done to the affected area. And in most cases the MRI will be able to diagnose the issues with relative ease, accuracy and expediency. Most Americans are familiar with MRIs […]